▼ 0.93%
prev close
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
-1
0 buys · 1 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2023-07-10 | FMSFresenius Medical Care AG | Sell | $1,001 - $15,000 | 963d ago | — |
2023-07-10
Daniel Goldman
FMS
Amount
$1,001 - $15,000
Filed
963d ago
Recent News
Powered by Polygon.io
U.S. Arteriovenous Fistula Devices Market Trends Analysis Report 2025-2033: Lucrative Opportunities Stem from Rising ESRD Cases, Driving Demand for AVF Solutions
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
Wearable Artificial Organs Global Market Research 2023-2024 & Forecasts to 2034: Government Funding and Initiatives, & Patient Preference for Non-Invasive Solutions Boost Growth
China Infusion Systems (Pumps & Pump Disposables) Market Outlook to 2033: Key Companies in China, Pipeline Products, Financial Deals Landscape, Recent Developments & More
United States Compounding Pharmacy Market Industry Outlook 2024-2029: Growing Demand for Compounded Bioidentical Menopausal Hormone Therapy (BMHT) Among Women Drives Market Growth
Trade Timeline
Congressional activity, newest first
Daniel Goldman
2023-07-10 · Sale
$1,001 - $15,000